Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
All cancer types, Breast cancer, Lung cancer, Non small cell lung cancer (NSCLC), Ovarian cancer, Stomach cancer
Closed
This study is looking at ceralasertib (AZD6738) for solid cancers that have spread to another part of the body. A is any cancer apart from cancers of the blood such as leukaemia and lymphoma.
There are 2 parts to this study. This summary is about the dose expansion study. We have another summary about the dose escalation study.
Recruitment start: 21 October 2014
Recruitment end: 11 September 2024
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Matthew Krebs
AstraZeneca
Experimental Cancer Medicine Centre (ECMC)
Last reviewed: 11 September 2024
CRUK internal database number: 14062
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
